Stories

A Marine Corps Veteran got an infusion of hope this week when he became the second patient in the state of Texas and the first Veteran in the country to receive a groundbreaking drug aimed at slowing the progression of amyotrophic lateral sclerosis (ALS).

Calling All Veterans - come learn about and apply for toxic exposure benefits!

The City of Galveston has notified the VA that the Galveston Outpatient Clinic will be without water on Tuesday, June 27th.

Dr. Bhavika Kaul, a researcher at the Michael E. DeBakey VA Medical Center in Houston, was named a National Academy of Medicine (NAM) Scholar in Diagnostic Excellence.

The Houston National Cemetery will hold their annual Memorial Day Commemoration Ceremony on May 29 at 9 a.m.

Last month, Houston Veteran Andrew Mefferd received a gold medal in creative writing in the national VA creative arts competition.

The Commission on Cancer (CoC), a quality program of the American College of Surgeons (ACS) has granted Three-Year Accreditation to the cancer program at Michael E. DeBakey VA Medical Center.

The Michael E. DeBakey VA Medical Center in Houston has been chosen as one of two sites nationwide to pilot a Food is Medicine Program aimed at improving the quality of life for Veterans living with or at risk of diet-related health conditions.

In March 2023, the Michael E. DeBakey VA Medical Center in Houston reached a new milestone by performing a transcatheter aortic valve replacement (TAVR) procedure that accessed the heart through the carotid artery in the neck.

In 2022, Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, rapidly progressed within Navy Veteran Thomas Bily, who served for 28 years on active duty as a pilot.